145 related articles for article (PubMed ID: 8597031)
1. Dose-response relationships of cytotoxicity, PFC response and histology in the spleen in rats treated with alkylating agents.
Doi T; Nagai H; Tsukuda R; Suzuki T
Toxicology; 1996 Jan; 107(1):47-60. PubMed ID: 8597031
[TBL] [Abstract][Full Text] [Related]
2. Repeated high dose oral exposure or continuous subcutaneous infusion of 2-methoxyacetic acid does not suppress humoral immunity in the mouse.
Riddle MM; Williams WC; Smialowicz RJ
Toxicology; 1996 May; 109(1):67-74. PubMed ID: 8619254
[TBL] [Abstract][Full Text] [Related]
3. Appropriate conditions for the plaque forming cell (PFC) assay in rats and effects of cyclophosphamide on PFC response.
Doi T; Nakai Y; Yamamoto M; Ando T
J Toxicol Sci; 1992 Nov; 17(4):225-33. PubMed ID: 1474615
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice.
Bin-Hafeez B; Ahmad I; Haque R; Raisuddin S
J Ethnopharmacol; 2001 Apr; 75(1):13-8. PubMed ID: 11282437
[TBL] [Abstract][Full Text] [Related]
5. Toxicological evaluation of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine (VNP40101M), a novel alkylating agent with potential antitumor activity, with intravenous administration in rats and dogs.
Lee KC; Almassian B; Noveroske J
Int J Toxicol; 2002; 21(1):23-38. PubMed ID: 11936896
[TBL] [Abstract][Full Text] [Related]
6. The influence of vehicle gavage on seasonality of immune system parameters in the B6C3F1 mouse.
Dozier MM; Ratajczak HV; Sothern RB; Thomas PT
Fundam Appl Toxicol; 1997 Aug; 38(2):116-22. PubMed ID: 9299184
[TBL] [Abstract][Full Text] [Related]
7. Synergistic lethal action of alkylating agents and sodium pentobarbital in the mouse.
Munson AE; Rose WC; Bradley SG
Pharmacology; 1974; 11(4):231-40. PubMed ID: 4218647
[No Abstract] [Full Text] [Related]
8. Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study.
Ladics GS; Smith C; Heaps K; Elliott GS; Slone TW; Loveless SE
Toxicology; 1995 Feb; 96(3):225-38. PubMed ID: 7900163
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxicity of 2-methoxyethanol following oral administration in Fischer 344 rats.
Smialowicz RJ; Riddle MM; Luebke RW; Copeland CB; Andrews D; Rogers RR; Gray LE; Laskey JW
Toxicol Appl Pharmacol; 1991 Jul; 109(3):494-506. PubMed ID: 1853347
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide effects on immune function of European starlings.
Trust KA; Fowles JR; Hooper MJ; Fairbrother A
J Wildl Dis; 1994 Jul; 30(3):328-34. PubMed ID: 7933273
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxicity of tributyltin oxide in rats exposed as adults or pre-weanlings.
Smialowicz RJ; Riddle MM; Rogers RR; Luebke RW; Copeland CB
Toxicology; 1989 Jul; 57(1):97-111. PubMed ID: 2749744
[TBL] [Abstract][Full Text] [Related]
13. Two immunotoxicity ring studies according to OECD TG 407-comparison of data on cyclosporin A and hexachlorobenzene.
Schulte A; Althoff J; Ewe S; Richter-Reichhelm HB;
Regul Toxicol Pharmacol; 2002 Aug; 36(1):12-21. PubMed ID: 12383714
[TBL] [Abstract][Full Text] [Related]
14. Immune alterations in rats following subacute exposure to tributyltin oxide.
Smialowicz RJ; Riddle MM; Rogers RR; Leubke RW; Copeland CB; Ernst GG
Toxicology; 1990 Nov; 64(2):169-78. PubMed ID: 2219138
[TBL] [Abstract][Full Text] [Related]
15. Differences between rats and mice in the immunosuppressive activity of 2-methoxyethanol and 2-methoxyacetic acid.
Smialowicz RJ; Riddle MM; Williams WC; Copeland CB; Luebke RW; Andrews DL
Toxicology; 1992 Aug; 74(1):57-67. PubMed ID: 1514188
[TBL] [Abstract][Full Text] [Related]
16. Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone.
Desikan KR; Tricot G; Dhodapkar M; Fassas A; Siegel D; Vesole DH; Jagannath S; Singhal S; Mehta J; Spoon D; Anaissie E; Barlogie B; Munshi N
Bone Marrow Transplant; 2000 Mar; 25(5):483-7. PubMed ID: 10713623
[TBL] [Abstract][Full Text] [Related]
17. The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats.
Exon JH; Henningsen GM; Koller LD; Talcott PA
Int J Immunopharmacol; 1986; 8(1):53-62. PubMed ID: 2420733
[TBL] [Abstract][Full Text] [Related]
18. Time-course study of the immunotoxic effects of the anticancer drug chlorambucil in the rat.
Pearse G; Pietersma A; Cunliffe J; Foster JR; Turton J; Derbyshire N; Randall KJ
Toxicol Pathol; 2009 Dec; 37(7):887-901. PubMed ID: 19805614
[TBL] [Abstract][Full Text] [Related]
19. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
Goldenberg GJ
Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma.
Huijgens PC; Dekker-Van Roessel HM; Jonkhoff AR; Admiraal GC; Zweegman S; Schuurhuis GJ; Ossenkoppele GJ
Bone Marrow Transplant; 2001 May; 27(9):925-31. PubMed ID: 11436102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
